等待开盘 09-06 09:30:00 美东时间
+0.570
+3.96%
YOKNEAM, Israel, Sept. 2, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Off...
09-02 20:30
YOKNEAM, Israel, Aug. 5, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following inv...
08-05 20:30
Needham analyst Mike Matson reiterates InMode (NASDAQ:INMD) from Hold to Hold.
07-31 00:38
Barclays analyst Matt Miksic maintains InMode (NASDAQ:INMD) with a Overweight and lowers the price target from $24 to $21.
07-30 21:17
InMode (NASDAQ:INMD) lowers FY2025 Adj EPS guidance from $1.64-$1.68 to $1.55-$1.59 vs $1.69 analyst estimate. Affirms FY2025 sales outlook from $365.000 million-$375.000 million to $365.000 million-$375.000 million vs
07-30 19:33
InMode (NASDAQ:INMD) is preparing to release its quarterly earnings on Wednesda...
07-30 05:02
Canaccord Genuity analyst Caitlin Cronin maintains InMode (NASDAQ:INMD) with a Hold and maintains $15 price target.
07-11 22:31
InMode shares are trading lower after the company cut its 2025 outlook.
07-10 19:07
YOKNEAM, Israel, May 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today sent a letter to DOMA Perpetual Capit...
05-28 20:30
Believes the Board Should Immediately Resume and Accelerate BuybacksAsserts Board Should Remove Moshe Mizrahy as CEO of the CompanyMIAMI, May 9, 2025 /PRNewswire/ -- DOMA Perpetual Capital Management LLC, a
05-09 20:28